NSE: SUNPHARMA

Sun Pharma: The Specialty Pivot and the Quest for Global Alpha

By StreetVantage Intelligence // September 23, 2026

₹₹1,865.00

BULLISH

DISCLAIMER: Educational intelligence only. StreetVantage is NOT SEBI registered. Trading involve risk of loss.